PROBeX: Study Reporting Plan SOP (1288)
Tracking study progress SOP for PROBeX.
Category Legend
Study Type(s)
Topic Area(s)
Document Type(s)
Study Method(s)
Document Method(s)
Tracking study progress SOP for PROBeX.
Protocol for PROBeX study.
Specimen freezer temperature monitoring protocol for TRAX study.
Refrigerator temperature monitoring protocol for TRAX study staff.
Monitoring site visits procedure for Emory RSPH staff in TRAX study.
Protocol for the PrEP 2-1-1 study, includes background, objectives, research locations, study population, study overview, PrEPsmart app, data management and analysis, safety monitoring and adverse event reporting, laboratory specimens and biohazard containment, administrative procedures, and references.
Protocol for DOT Diary Study, includes; background, study objectives, research locations, study population, study design, data management and analysis, safety monitoring and adverse event reporting, laboratory specimens and biohazard containment, administrative procedures, references.
Eligibility screening survey script for the PrEP@Home Study.
Baseline survey including demographics, gender identity, race and ethnicity, education, employment, healthcare coverage, health access and engagement, health literacy, acute symptoms, marital status, HIV/STI testing history, sexual history, basic HIV knowledge, perceived HIV risk, PEP awareness, PrEP knowledge/attitudes, PrEP intentions, PrEP stigma, sexual stigma, outness to provider, mental health, resiliency, substance use, willingness to pay, income, housing stability, and use of social/geosocial networking sites for the PrEP@Home Study.
1 month participant follow up survey for the PrEP@Home Study.
Follow-up survey including adherence, side effects, acute symptoms, sexual history, PrEP stigma, PHQ-2/GAS-2 screener, substance use, CAGE-AID questions, housing, SUS, healthcare coverage, cost, and use of social/geosocial networking sites for the PrEP@Home Study.
IRB reportable adverse events and protocol deviation SOP for the PrEP@Home Study.
Staff delivering HIV test results SOP for the PrEP@Home Study.
Recruitment, eligibility screening, and informed consent SOP for the PrEP@Home Study.
PrEP side effect management SOP outlining the procedures for study staff to counsel participants on PrEP side effects in the PrEP@Home Study.
Linkage to PrEP care SOP for control and intervention participants who have finished the PrEP@Home Study.
Laboratory and specimen procedure SOP for the PrEP@Home Study.
Follow-up Visit SOP describing how staff handles follow up visits beyond the baseline visits for the PrEP@Home Study.
Enrollment SOP describing how staff handles the enrollment process for all participants in the PrEP@Home Study, including study visit eligibility, baseline visit, enrollment, and randomization.
SOP for collecting INSTI HIV-1/HIV-2 Antibody Test blood samples for the PrEP@Home Study.
ClinCard website reference guide for clinics in the PrEP@Home Study.
Written process for the PrEP@Home admin dashboard for the PrEP@Home Study.
Scripts for phone call study introduction and email study visit reminder for the PrEP@Home Study.
Text and phone script for baseline visit and reminders for study participants in the PrEP@Home Study.
Compilation of recruitment materials, including written information, taglines, advertisement body text, photos, sample graphics, and study logos for the PrEP@Home Study.
Palm card advertisement for recruiting participants for the PrEP@Home Study.
Executive summary of the PrEP@Home Study.
Flow chart of the PrEP@Home Study timeline.
Expanded standard protocol including introduction, methods, study overview, study intervention, trial design, procedures, laboratory specimens and procedures, safety monitoring and adverse event reporting, statistical considerations, human subjects considerations, administrative procedures, and references for the PrEP@Home Study.
Protocol for collaborating with non-Emory researchers to determine whether a Reliance Agreement is necessary/appropriate for the PrEP@Home Study.
Initial review worksheet for institutions and their local context for the PrEP@Home Study.
Emory IRB reliance request form for the PrEP@Home Study.
HIPAA and informed consent waiver for the PrEP@Home Study.
HIPAA waiver for the PrEP@Home Study.
IRB tracking spreadsheet for the PrEP@Home Study.
PowerPoint of data and safety results and next steps for the PrEP@Home Study.
Data safety and monitoring plan guidelines for the PrEP@Home Study.
Study stop CRF for participant withdrawal from the PrEP@Home Study.
Social harms event CRF for the PrEP@Home Study.
Randomization CRF form for the PrEP@Home Study.
Protocol deviation CRF for the PrEP@Home Study.
Medical provider CRF form for the PrEP@Home Study.
1 month follow-up CRF for the PrEP@Home Study.
Initial eligibility CRF for the PrEP@Home Study.
Final eligibility CRF for the PrEP@Home Study.
CRF from Division of AIDS (DAIDS), U.S. Department of Health and Human Services: Severity grading table for adult and pediatric adverse events for the PrEP@Home Study.
“Study consent form for Metro Health Medical Center for the PrEP@Home Study.
Study consent form for Washington University in St. Louis Health Center for the PrEP@Home Study.
Study consent form for UMMC Health Center for the PrEP@Home Study.